Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma
- DOI
- 10.1186/s13046-024-03253-y
- Published
- 2024-12-21
- Container
- Journal of Experimental & Clinical Cancer Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13046-024-03253-y,
title = {Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma},
author = {I. C. Salaroglio and P. Aviles and J. Kopecka and A. Merlini and F. Napoli and L. Righi and S. Novello and H. Sullivan and C. Cuevas and G. V. Scagliotti and C. Riganti},
year = {2024},
journal = {Journal of Experimental \& Clinical Cancer Research},
doi = {10.1186/s13046-024-03253-y},
url = {https://doi.org/10.1186/s13046-024-03253-y}
}RIS
TY - JOUR TI - Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma AU - I. C. Salaroglio AU - P. Aviles AU - J. Kopecka AU - A. Merlini AU - F. Napoli AU - L. Righi AU - S. Novello AU - H. Sullivan AU - C. Cuevas AU - G. V. Scagliotti AU - C. Riganti PY - 2024 JO - Journal of Experimental & Clinical Cancer Research DO - 10.1186/s13046-024-03253-y UR - https://doi.org/10.1186/s13046-024-03253-y ER -
APA
Salaroglio, I. C., Aviles, P., Kopecka, J., Merlini, A., Napoli, F., Righi, L., Novello, S., Sullivan, H., Cuevas, C., Scagliotti, G. V., & Riganti, C. (2024). Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-024-03253-y
Source records
- crossref · retrieved 2026-09-25T14:20:55.277Z